Answers are grounded in this paper and cite their sources.
A9145 is a new adenine-containing antifungal antibiotic. A9145 showed weak in vitro activity against Candida albicans in SABOURAUD'S medium, but was strongly inhibitory in a chemically defined medium. Viability counts of C. albicans following extended exposure to A9145 indicated a fungistatic action. Following a 100mg/kg dose, a peak of 64μg/mlof A9145 activity was detected in mouse blood. Administration of 10 mg/kg for 3 days extended the survival time of mice infected with C. albicans 128%; equivalent doses of amphotericin B extended survival time 112%. A total dose of 31.25 mg/kg administered over a 5-day period reduced by 400-fold the number of Candida recovered from kidney homogenates of infected mice. A combination of amphotericin B and A9145 caused a possible synergistic effect against C. albicans in vitro and an additive effect in vivo.
No takes yet. Share an insight, caveat, or question.
Gordee et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: